Skip to main content
TipRanks
Go Ultimate75% OFF

Genpact (35G) Stock Price & Analysis

3 Followers

35G Stock Chart & Stats

€38.70€0.33(0.86%)
At close: 5:30 PM GMT+1
€28€30€32€34Aug 14Sep 28Oct 21
Day’s Range
EUR 38.70 - EUR 38.70
52-Week Range
EUR 23.72 - EUR 41.27
Previous Close
EUR 38.37
Volume
N/A
Average Volume (3M)
2
Market Cap
EUR 6.54B
Enterprise Value
EUR 6.42B
Total Cash (Recent Filing)
EUR 499.05M
Total Debt (Recent Filing)
EUR 1.39B
Price to Earnings (P/E)
12.6
Beta
0.22
Next Earnings
Feb 11, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
1.62%

Bulls Say, Bears Say

Bulls Say

Advanced Technology Solutions Growth

Rapid ATS growth shows that Genpact is successfully shifting toward higher-value technology, analytics, and AI-enabled services. This mix change can support stronger productivity, deeper client relationships, and more durable growth than reliance on traditional outsourced operations alone.

Recurring Revenue Model

A high share of annuitized and recurring revenue improves visibility and strengthens client retention economics. Longer-duration contracts can create a durable base for cash generation, while recurring agentic work gives Genpact opportunities to expand relationships as client processes become more technology-enabled.

Improved Balance Sheet

Lower leverage and continued equity growth give Genpact greater financial flexibility to invest in technology, pursue strategic opportunities, and withstand uneven demand. Strong low-20% TTM return on equity also indicates that the business is generating attractive returns on its capital base.

Bears Say

Transition Away From Non-strategic Work

Exiting work that does not fit the Agentic Operations strategy should improve long-term mix, but it creates a multi-period revenue headwind during the transition. The continuing impact into 2027 raises execution risk and means reported growth may lag underlying strategic progress.

Weaker Cash-flow Conversion

Delayed invoicing and collections temporarily weakened operating cash flow and reduced the conversion of earnings into cash. Even if management expects normalization, the episode shows that major process changes can pressure liquidity and may constrain near-term funding for investment or shareholder returns.

Early-stage Agentic Execution

Strong agentic bookings do not immediately translate into reported revenue because implementations require foundational work and longer deployment timelines. This conversion gap increases execution complexity, delays financial benefits, and leaves growth dependent on successfully scaling delivery across client programs.

Genpact News

35G FAQ

What was Genpact’s price range in the past 12 months?
Genpact lowest stock price was €23.72 and its highest was €41.27 in the past 12 months.
What is Genpact’s market cap?
Genpact’s market cap is €6.54B.
When is Genpact’s upcoming earnings report date?
Genpact’s next earnings report is estimated for Feb 11, 2027 (not yet confirmed), which is in 88 days.
How were Genpact’s earnings last quarter?
Genpact released its earnings results on Nov 05, 2026. The company reported €0.958 earnings per share for the quarter, beating the consensus estimate of €0.935 by €0.023.
Is Genpact overvalued?
According to Wall Street analysts Genpact’s price is currently Undervalued.
Does Genpact pay dividends?
Genpact does not currently pay dividends.
What is Genpact’s EPS estimate?
Genpact’s EPS estimate is 0.98.
How many shares outstanding does Genpact have?
Genpact has 167,226,990 shares outstanding.
What happened to Genpact’s price movement after its last earnings report?
Genpact reported an EPS of €0.958 in its last earnings report, beating expectations of €0.935. Following the earnings report the stock price went up 7.005%.
Which hedge fund is a major shareholder of Genpact?
Hedge funds hold Genpact shares: the largest hedge-fund position in Genpact is 1,162,585,016 shares, and hedge funds increased their holdings by 1.2M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology